Brief: Panbela Provides Business Update And Reports Q3 2022 Financial Results
10/11/2022 22:15
Nov 10 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA PROVIDES BUSINESS UPDATE AND REPORTS Q3 2022
FINANCIAL
RESULTS
* PANBELA THERAPEUTICS INC- NET LOSS IN Q3 OF 2022 WAS $4.4
MILLION, OR $0.21PER DILUTED SHARE
* PANBELA THERAPEUTICS INC- TOTAL CASH WAS $0.9 MILLION AS
OF
SEPTEMBER 30, 2022
Source text for Eikon: ID:nGNX7S4J7F
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants